当前位置:
X-MOL 学术
›
Eur. Urol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Re: Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
European Urology ( IF 25.3 ) Pub Date : 2022-08-09 , DOI: 10.1016/j.eururo.2022.07.030 Claudia Kesch 1 , Boris A Hadaschik 1
European Urology ( IF 25.3 ) Pub Date : 2022-08-09 , DOI: 10.1016/j.eururo.2022.07.030 Claudia Kesch 1 , Boris A Hadaschik 1
Affiliation
Abstract not available
中文翻译:
回复:低风险或中等风险局限性前列腺癌患者的主动监测加恩杂鲁胺单一疗法与单独主动监测:ENACT 随机临床试验
摘要不可用
更新日期:2022-08-09
中文翻译:
回复:低风险或中等风险局限性前列腺癌患者的主动监测加恩杂鲁胺单一疗法与单独主动监测:ENACT 随机临床试验
摘要不可用